Conference Coverage

Air pollution tied to ventricular arrhythmias in those with ICDs


 

FROM ESC HEART FAILURE 2022

Entering the mainstream

In a comment, Joel Kaufman, MD, MPH, professor of internal medicine and environmental health, University of Washington, Seattle, said the study “adds to a fairly substantial literature already on this topic of short-term exposure to air pollution.”

The evidence that air pollutants “can be a trigger of worsening of cardiovascular disease is fairly consistent at this time, and although the effect sizes are small, they are consistent,” said Dr. Kaufman, who was the chair of the writing group for the American Heart Association’s 2020 policy statement, “Guidance to Reduce Cardiovascular Burden of Ambient Air Pollutants.”

“The research into this issue has become clearer during the past 10 years but still is not in the mainstream of most cardiologists’ awareness. They tend to focus more on controlling cholesterol and performing procedures, etc., but there are modifiable risk factors like air pollution that are increasingly recognized as being part of the picture,” said Dr. Kaufman, who was not involved with the current study.

Dr. Zanni added: “It is important that politics work hand in hand with the scientific community in order to win the battle against global warming, which will reduce the number of cardiovascular deaths – the leading cause of death worldwide – as well as environmental integrity.”

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Dr. Zanni and coauthors and Dr. Kaufman reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Voice-analysis app promising as early warning system for heart failure decompensation
MDedge Internal Medicine
Takotsubo syndrome more deadly in men
MDedge Internal Medicine
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
MDedge Internal Medicine
Paradigm-challenging heart failure treatment strategy hopeful in early trial
MDedge Internal Medicine
Path to parenthood in cardiology training fraught with obstacles
MDedge Internal Medicine
ADA prioritizes heart failure in patients with diabetes
MDedge Internal Medicine
Will tirzepatide slow kidney function decline in type 2 diabetes?
MDedge Internal Medicine
Antidiabetes drug costs keep patients away
MDedge Internal Medicine
SGLT2 inhibitors cut AFib risk in real-word analysis
MDedge Internal Medicine
Cause of death in pig heart recipient: New clues
MDedge Internal Medicine